CDMOs offering Biologics Development & Manufacturing with Biologics (Monoclonal Antibodies)
Biologics Development & Manufacturing combined with Biologics (Monoclonal Antibodies) is a common shortlist filter for sponsors evaluating CDMO partners. This explore page lists organizations that publicly map to both dimensions, so you can move from taxonomy browsing to a tighter candidate set without rebuilding filters from scratch.
Profiles here are fit-first: open each listing for scope, geography, regulatory posture, and provenance-backed facts. The directory does not rank these rows as a single "best" answer — use them to assemble a right-sized outreach list for your program stage and quality bar.
When you need adjacent criteria (indications, claim status, or cross-category search), continue to the main search experience and layer filters on top of this service × modality starting point.
Auto-generated by BioBM Editorial AI.
Matching companies
- ACS Dobfar
Italian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.
- AGC Biologics
Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.
- AbbVie Contract Manufacturing
Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe.
- Abzena
Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.
- Asimov
Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.
- AsymBio
AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.
- Aurobindo Pharma CDMO
Aurobindo Pharma Limited is one of the largest generic pharmaceutical companies globally, with a strong commitment to making medicines affordable and accessible.
- Avid Bioservices
Avid Bioservices is a U.S.-based mammalian cell culture CDMO providing integrated process development, analytical development, and CGMP biologics manufacturing from DNA to IND to commercial supply, with 30+ years of expertise and FDA-inspected facilities in California.
- BSP Pharmaceuticals
BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.
- Biocon
Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases.
- Bionova Scientific
Biologics CDMO specializing in mAbs and recombinant protein therapeutics using mammalian cell culture, offering development and GMP manufacturing services.
- Catalent
Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
- Celonic
Swiss-based pure-play biologics CDMO specializing in next-generation bioprocessing technologies including process intensification and full perfusion to reduce cost of goods for biotech and biosimilar clients.
- Charles River Laboratories
Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
- Creative Biolabs
Creative Biolabs provides custom recombinant antibody production, high-throughput antibody screening, GMP antibody manufacturing, and antibody biosimilar development services for biomedical research and therapeutic development.
- Curia
Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.
- Cytovance Biologics
U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.
- Dr. Reddy's Laboratories
Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.
- Enzene Biosciences
Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.
- FUJIFILM Biotechnologies
CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.
- Gannet Biochem
Specialized CDMO offering custom polymer science, PEG chemistry, bioconjugation, and cGMP manufacturing services from early discovery through commercial scale, with 30+ years of expertise rooted in Shearwater Polymers and Nektar Therapeutics.
- Grand River Aseptic Manufacturing
Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines.
- Icosagen
Icosagen is an integrated CRDMO (Contract Research, Development & Manufacturing Organization) specializing in antibody discovery, protein production, cell line development, and GMP manufacturing for biologics programs from discovery through commercial scale.
- JSR Life Sciences
CDMO and CRO offering downstream processing, protein purification, and manufacturing capabilities for therapeutic antibodies and biologics from discovery through commercialization.
- KBI Biopharma, Inc.
Global CDMO offering cell line development, process and analytical development, formulation development, and clinical and commercial manufacturing for mammalian and microbial biologics.
- Lonza Cell & Gene Technologies
Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.
- National Resilience
End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.
- Patheon (Thermo Fisher Pharma Services)
Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing.
- Pfizer CentreOne
Award-winning CDMO specializing in commercial manufacturing of oral solids, sterile injectables, and biologic drug products with Pfizer's technical expertise and global network.
- Pharmaron
Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- Piramal Pharma Solutions
CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- Rodon Biologics
Rodon Biologics is a biotech CRO/CDMO with over 20 years of activity. It offers protein engineering, recombinant protein production, cell line and process development, manufacturing, and analytical and stability testing services for biologics.
- Samsung Biologics
Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
- Scinai Immunotherapeutics Ltd.
Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
- Simtra BioPharma Solutions
Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.
- Syngene International
Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- WuXi Biologics
Global biologic CDMO offering end-to-end solutions from discovery to commercialization.
- WuXi Vaccines
Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.
- Yapan Bio
Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Related: Biologics Development & Manufacturing service page · Biologics (Monoclonal Antibodies) modality page
Markdown mirror: /explore/svc_biologics_dev_mfg/mod_biologics_mab.md